Answers are grounded in this paper and cite their sources.
Condensation of pyridine-2-carbonitrile (2-CNpy) with 2-aminoethanol (L1), l-amino-2-propanol (L2) and 2-amino-l-butanol (L3) in ethanolic solutions of Ni(II) salts proceeded readily at room temperature to form stable complexes, which contain the amino form of N-hydroxy-alkylpyridine-2-carboxamidines (amL-NH2). The crystal structure of complex [Ni(N-2-hydroxyethylpyridine-2-carboxamidine)2]Cl2 · 3.5H2O and IR data confirm N,N,O-coordination of N-hydroxyalkylpyridine-2-carboxamidines (via the nitrogen atom of the pyridine ring, the nitrogen atom of the C = N- group and the oxygen atom of the hydroxyl group). The electron density distribution and structure of the amino form of amL-NH2 are suitable for cyclization accompanied by ammonia elimination and formation of the appropriate oxazoline. On the other hand, substituted 2-amino-2-ethyl-l,3-propandiol (L4) formed in alcoholic solutions of Ni(II) complexes containing 2-(2-pyridinyl)-4-ethyl-4-hydroxymethyl-2-oxazoline (oxaL4) only. The influence of amino alcohols and nickel(II) salts, as well as reaction conditions on amidine or oxazoline formation is discussed.
No takes yet. Share an insight, caveat, or question.
Segľa et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: